SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001178913-23-003119
Filing Date
2023-09-11
Accepted
2023-09-11 12:44:16
Documents
1
Period of Report
2023-09-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 10375
  Complete submission text file 0001178913-23-003119.txt   12626
Mailing Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852
Business Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852 732 545 1590
Ayala Pharmaceuticals, Inc. (Issuer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address HANNAH RUBINA 11 TEL AVIV L3 6937215
Business Address HANNAH RUBINA 11 TEL AVIV L3 6937215 972-52-873-9833
Israel Biotech Fund I, L.P. (Reporting) CIK: 0001652458 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36138 | Film No.: 231247285

Mailing Address PEKERIS 3 REHOVOT L3 670203
Business Address PEKERIS 3 REHOVOT L3 670203 972-72-251-4175
Israel Biotech Fund II, L.P. (Reporting) CIK: 0001782947 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36138 | Film No.: 231247284